Chodakewitz Jeffrey 4
4 · Praxis Precision Medicines, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Praxis (PRAX) Director Jeffrey Chodakewitz Receives Stock Awards
What Happened Jeffrey Chodakewitz, a director of Praxis Precision Medicines (PRAX), received equity awards on June 10, 2026. The filing reports (1) 1,371 restricted stock units (RSUs) and (2) 648 derivative awards, each acquired at $0 (reported as grant/award, code A). These are compensation grants, not open-market purchases or sales, so no cash changed hands at grant.
Key Details
- Transaction date: 2026-06-10; Form 4 filed 2026-06-12 (timely).
- Reported amounts and price: 1,371 RSUs @ $0; 648 derivative awards @ $0; reported total value $0 (no purchase price).
- Vesting:
- 1,371 RSUs vest in a single annual installment on the earlier of June 10, 2027 or the 2027 annual meeting (F1). RSUs settle only in shares.
- 648 derivative awards vest in 12 equal monthly installments starting July 10, 2026 through the earlier of June 10, 2027 or the 2027 annual meeting (F2).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Transaction code: A = award/grant. No 10b5-1 plan, tax-withholding, or late-filing flags disclosed in this filing.
Context These are standard equity compensation grants to a board member and are recorded at $0 because they are awards rather than purchases. RSUs and the listed derivative awards are subject to vesting schedules; they become economically meaningful only as they vest and are settled into shares. Such grants are common for directors and are part of compensation practices rather than direct signals of buying or selling by the insider.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-10+1,371→ 1,371 total - Award
Stock Option (Right to Buy)
[F2]2026-06-10+648→ 648 totalExercise: $240.66Exp: 2036-06-10→ Common Stock (648 underlying)
Footnotes (2)
- [F1]Dr. Chodakewitz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.